Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 15:17:801-814.
doi: 10.2147/CMAR.S511962. eCollection 2025.

Impact of the Timing of Protective Stoma Reversal on Survival in Rectal Cancer Patients Undergoing Postoperative Adjuvant Chemotherapy: A Retrospective Single Center Study

Jiwei Wang #  1 , Xiaoyun Lu #  1 , Yanan Xu  1 , Yin Wu  1 , Tao Zhang  1 , Jianguo Li  1
Affiliations

Impact of the Timing of Protective Stoma Reversal on Survival in Rectal Cancer Patients Undergoing Postoperative Adjuvant Chemotherapy: A Retrospective Single Center Study

Jiwei Wang et al. Cancer Manag Res. .

Abstract

Background: Postoperative adjuvant chemotherapy used in patients with stage II/III rectal cancer, is usually administered for 3 to 6 months. However, the optimal timing of protective stoma reversal remains controversial. This study aimed to investigate the effect of stoma closure before or after adjuvant chemotherapy on survival and stoma-related complications.

Methods: A retrospective analysis was conducted on 144 patients who underwent radical rectal cancer surgery, prophylactic ileostomy and adjuvant chemotherapy from June 2018 to June 2021. 104 had their stoma reversal before adjuvant chemotherapy completion (Before group) and 40 after adjuvant chemotherapy completion (After group).

Results: There were no significant differences between the groups regarding demographics, clinical characteristics, perioperative complications, OS, or DFS. Pathologic T-stage [HR = 2.620 (1.291-5.320), P = 0.008 vs HR = 2.793 (1.297-6.017), P = 0.009] and N-stage [HR = 2.204 (1.168-4.157), P = 0.015 vs HR = 2.068 (1.125-3.789), P = 0.019] were identified as independent risk factors for OS and DFS. Stoma reversal after completing chemotherapy [OR = 39.979 (3.964-403.188), P = 0.002] and comorbidity [OR = 33.395 (5.931-188.033), P < 0.001] were independent risk factors for stoma-related complications. In high-risk stage III patients with T4 or N2, the 3-year OS rate was significantly lower in Before group than in After group (70.3% vs 92.6%, P = 0.01), as was the 3-year DFS rate (60.94% vs 74.07%, P = 0.02). Prolonged stoma duration [HR = 0.991 (0.982-1.000), P = 0.048] was an OS protective factor. Stoma reversal after chemotherapy [HR = 0.370 (0.141-0.972), P = 0.044] and cumulative 5-FU dosage [HR = 0.991 (0.985-0.997), P = 0.003] were DFS protective factors.

Conclusion: In high-risk stage III patients, delayed stoma reversal after adjuvant chemotherapy may improve survival, but it may also lead to more stoma-related complications.

Keywords: adjuvant chemotherapy; protective ileostomy; rectal cancer; stoma-related complications; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests in this work.

Figures

Figure 1
Figure 1
Study flowchart.
Figure 2
Figure 2
OS and DFS survival curves between the two groups in the entire cohort.
Figure 3
Figure 3
OS and DFS survival curves between the two groups in high-risk stage III rectal cancer.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Lee BC, Lim SB, Lee JL, et al. Defunctioning protective stoma can reduce the rate of anastomotic leakage after low anterior resection in rectal cancer patients. Ann Coloproctol. 2020;36(3):192–197. doi:10.3393/ac.2019.11.19.1 - DOI - PubMed
    1. Wang FG, Yan WM, Yan M, et al. Comparison of anastomotic leakage rate and reoperation rate between transanal tube placement and defunctioning stoma after anterior resection: a network meta-analysis of clinical data. Eur J Surg Oncol. 2019;45(8):1301–1309. doi:10.1016/j.ejso.2019.01.182 - DOI - PubMed
    1. Keane C, Park J, Oberg S, et al. Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer. Br J Surg. 2019;106(5):645–652. doi:10.1002/bjs.11092 - DOI - PMC - PubMed
    1. Elsner AT, Brosi P, Walensi M, et al. Closure of temporary ileostomy 2 versus 12 weeks after rectal resection for cancer: a word of caution from a prospective, randomized controlled multicenter trial. Dis Colon Rectum. 2021;64(11):1398–1406. doi:10.1097/DCR.0000000000002182 - DOI - PMC - PubMed
    1. Tramontano S, Sarno G, Iacone B, et al. Early versus late closure of protective loop ileostomy: functional significant results in a preliminary analysis. Minerva Surg. 2024;79(4):435–442. doi:10.23736/S2724-5691.24.10305-X - DOI - PubMed

LinkOut - more resources